Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 448 followers

Latest posts

Last updated about 10 hours ago

Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 5, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation...

Sponsor guidance: New safety module on the annual safety report

about 10 hours ago

Sponsor guidance: New safety module on the annual safety report

Support to SMEs

about 11 hours ago

Support to SMEs

PSUSA/00000414/202601

about 11 hours ago

PSUSA/00000414/202601

PSUSA/00010209/202601

about 11 hours ago

PSUSA/00010209/202601

Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis Weston,Fragaria x ananassa (Weston) Duchesne ex Rozier , F: Assessment finalised

about 11 hours ago

Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis...

Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 4, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation...

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised

about 11 hours ago

Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of...

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 19, Status: Authorised

about 12 hours ago

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil...

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised

about 13 hours ago

Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan)...

Minutes of PRAC meeting on 8-11 June 2026

about 16 hours ago

Minutes of PRAC meeting on 8-11 June 2026

Podcast: Inside EMA

about 13 hours ago

Podcast: Inside EMA